Search Results - "Nerich V"

Low exposure to sunlight is a risk factor for Crohn's disease.

Authors: Nerich, V. Jantchou, P. Boutron‐Ruault, M.‐C. et al.

Source: Alimentary Pharmacology & Therapeutics. Apr2011, Vol. 33 Issue 8, p940-945. 6p. 2 Charts, 2 Maps.

EE38 Leveraging National Real-World Evidence to Understand Differences of Economic Burden in Rare Diseases: The Case of Von Willebrand Disease in France.

Authors: Nerich, V Biron Andreani, C Trossaërt, M et al.

Source: Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS61-S61. 1p.

Computerized physician order entry of injectable antineoplastic drugs: An epidemiologic study of prescribing medication errors

Authors: Nerich, V. Limat, S. Demarchi, M. et al.

Source: International Journal of Medical Informatics. Oct2010, Vol. 79 Issue 10, p699-706. 8p.

Subjects: Electronic procurement, Antineoplastic agents, Epidemiological research, Medication errors, Medical informatics, Physicians, University hospitals

Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.

Authors: Nerich, V Borg, C Villanueva, C et al.

Source: Journal of Oncology Pharmacy Practice. Mar2013, Vol. 19 Issue 1, p8-17. 10p. 1 Diagram, 4 Charts.

3604 POSTER First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC): Cost Minimisation Analysis

Authors: Compagnat, F. Nerich, V. Bazan, F. et al.

Source: European Journal of Cancer. Sep2011 Supplement 1, Vol. 47, pS260-S260. 1p.

9 - Geographic distribution of inflammatory bowel disease (IBD) in France is influenced by sunlight exposure

Authors: Nerich, V. Monnet, E. Boutron, M. et al.

Source: Journal of Crohn's & Colitis. Feb2009, Vol. 3 Issue 1, pS6-S7. 0p.

C-07 Place de la caspofungine en hemato-pediatrie au chu de besançon

Authors: Khayat, N. Nerich, V. Menat, C. et al.

Source: Medecine & Maladies Infectieuses. Jun2004 Supplement 1, Vol. 34, pS144-S144. 1p.

Hospital Costs of Renal Transplant Management

Authors: Chaumard, N. Fagnoni, P. Nerich, V. et al.

Source: Transplantation Proceedings. Dec2008, Vol. 40 Issue 10, p3440-3444. 5p.

182 (PB-095) Poster - Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis.

Authors: Curtit, E. Bellanger, M. Nerich, V. et al.

Source: European Journal of Cancer. 2022 Supplement 1, Vol. 175, pS59-S59. 1p.

Incidence and risk-factors of CHOP/R- CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.

Authors: Limat, S. Daguindau, E. Cahn, J.‐Y. et al.

Source: Journal of Clinical Pharmacy & Therapeutics. Apr2014, Vol. 39 Issue 2, p168-174. 7p.

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.

Authors: Royer, B Kalbacher, E Onteniente, S et al.

Source: British Journal of Cancer. 1/31/2012, Vol. 106 Issue 3, p460-467. 8p. 1 Diagram, 3 Charts, 2 Graphs.

895P Cost effectiveness of stereotactic ablative radiotherapy (SABR) alone in comparison with systemic treatment and SABR in oligometastatic head and neck cancer in the GORTEC 2014-04 OMET randomized phase II study.

Authors: Thariat, J. Falcoz, A. Nadin, L. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS634-S634. 1p.

PCN202 - Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D.

Authors: Kemmler, G Gamper, E Nerich, V et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA744-A745. 1p.

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study.

Authors: Gaiffe, E. Crepin, T. Bamoulid, J. et al.

Source: Trials. 6/21/2019, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p. 1 Chart.

PT41 Real-World Evidence in Rare Diseases in France: Treatment Patterns, Healthcare Resource Use, and Related Costs in Von Willebrand Disease (FORvWARD Study).

Authors: Trossaërt, M. Biron Andreani, C. Marant Micallef, C. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 12, pS540-S540. 1p.

La mucite post-allogreffe de cellules souches hématopoïétiques : facteurs de risque, conséquences cliniques et prévention.

Authors: Bourdelin, M. Daguindau, E. Larosa, F. et al.

Source: Pathologie Biologie. Apr2015, Vol. 63 Issue 2, p106-110. 5p.

Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.

Authors: Thiery-Vuillemin, A. Mouillet, G. Nguyen Tan Hon, T. et al.

Source: Cancer Chemotherapy & Pharmacology. May2014, Vol. 73 Issue 5, p999-1007. 9p.

POSC134 Cost-Effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer.

Authors: Pelloux-Prayer, R Schiele, P Oudard, S et al.

Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS113-S113. 1p.

1114 Influence of time to initiation of adjuvant chemotherapy after orchidectomy in patients with stage I germinal testicular tumour on survival.

Authors: Mouillet, G. Nguyen Tan Hon, T. Kalbacher, E. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe1114-e1114. 1p.

Long-term survival of patients with HER2 metastatic breast cancer treated by targeted therapies.

Authors: Fiteni, F. Villanueva, C. Bazan, F. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1661-1661. 1p.